File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1056/NEJMc052065
- Scopus: eid_2-s2.0-26444483324
- PMID: 16221792
- WOS: WOS:000232486000033
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply
Title | Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply |
---|---|
Authors | |
Issue Date | 2005 |
Publisher | Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/ |
Citation | New England Journal of Medicine, 2005, v. 353 n. 15, p. 1630-1631 How to Cite? |
Description | Letters |
Persistent Identifier | http://hdl.handle.net/10722/43078 |
ISSN | 2023 Impact Factor: 96.2 2023 SCImago Journal Rankings: 20.544 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, K | en_HK |
dc.contributor.author | Rajvanshi, P | en_HK |
dc.contributor.author | Orlent, H | en_HK |
dc.contributor.author | Lau, GKK | en_HK |
dc.date.accessioned | 2007-03-23T04:38:22Z | - |
dc.date.available | 2007-03-23T04:38:22Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | New England Journal of Medicine, 2005, v. 353 n. 15, p. 1630-1631 | en_HK |
dc.identifier.issn | 0028-4793 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/43078 | - |
dc.description | Letters | - |
dc.format.extent | 60200 bytes | - |
dc.format.extent | 3155 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | text/plain | - |
dc.language | eng | en_HK |
dc.publisher | Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/ | en_HK |
dc.relation.ispartof | New England Journal of Medicine | - |
dc.rights | From New England Journal of Medicine, Kenneth Song, Pankaj Rajvanshi, Hans Orlent, George K.K. Lau, Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine, vol. 353, p. 1630-1631. Copyright © 2005 Massachusetts Medical Society. Reprinted with permission. | en_HK |
dc.subject.mesh | Antiviral agents - therapeutic use | en_HK |
dc.subject.mesh | Hepatitis b virus - drug effects - genetics | en_HK |
dc.subject.mesh | Hepatitis b, chronic - drug therapy | en_HK |
dc.subject.mesh | Interferon alfa-2a - therapeutic use | en_HK |
dc.subject.mesh | Polyethylene glycols - therapeutic use | en_HK |
dc.title | Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply | en_HK |
dc.type | Article | en_HK |
dc.description.nature | published_or_final_version | en_HK |
dc.identifier.doi | 10.1056/NEJMc052065 | - |
dc.identifier.pmid | 16221792 | en_HK |
dc.identifier.scopus | eid_2-s2.0-26444483324 | - |
dc.identifier.hkuros | 115851 | - |
dc.identifier.volume | 353 | - |
dc.identifier.issue | 15 | - |
dc.identifier.spage | 1630 | - |
dc.identifier.epage | 1631 | - |
dc.identifier.isi | WOS:000232486000033 | - |
dc.identifier.issnl | 0028-4793 | - |